Effects of β
Adrenergic beta-2 Receptor Agonists
/ administration & dosage
Adrenergic beta-Antagonists
/ administration & dosage
Aged
Bisoprolol
/ administration & dosage
Carvedilol
/ administration & dosage
Cross-Over Studies
Double-Blind Method
Female
Heart Failure
/ drug therapy
Humans
Indans
/ administration & dosage
Male
Middle Aged
Prospective Studies
Quinolones
/ administration & dosage
Receptors, Adrenergic, beta-2
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 04 2020
28 04 2020
Historique:
received:
10
12
2019
accepted:
24
02
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Alveolar β
Identifiants
pubmed: 32345990
doi: 10.1038/s41598-020-62644-1
pii: 10.1038/s41598-020-62644-1
pmc: PMC7188807
doi:
Substances chimiques
Adrenergic beta-2 Receptor Agonists
0
Adrenergic beta-Antagonists
0
Indans
0
Quinolones
0
Receptors, Adrenergic, beta-2
0
Carvedilol
0K47UL67F2
indacaterol
8OR09251MQ
Bisoprolol
Y41JS2NL6U
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7101Références
Carr, R. 3rd et al. beta-arrestin-biased signaling through the beta2-adrenergic receptor promotes cardiomyocyte contraction. Proceedings of the National Academy of Sciences of the United States of America 113, E4107–4116, https://doi.org/10.1073/pnas.1606267113 (2016).
doi: 10.1073/pnas.1606267113
pubmed: 27354517
pmcid: 4948363
Santulli, G. & Iaccarino, G. Adrenergic signaling in heart failure and cardiovascular aging. Maturitas 93, 65–72, https://doi.org/10.1016/j.maturitas.2016.03.022 (2016).
doi: 10.1016/j.maturitas.2016.03.022
pubmed: 27062709
pmcid: 5036981
Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of beta-adrenergic signaling in heart failure? Circulation Research 93, 896–906, https://doi.org/10.1161/01.RES.0000102042.83024.CA (2003).
doi: 10.1161/01.RES.0000102042.83024.CA
pubmed: 14615493
Lang, D. et al. Arrhythmogenic remodeling of beta2 versus beta1 adrenergic signaling in the human failing heart. Circulation. Arrhythmia and Electrophysiology 8, 409–419, https://doi.org/10.1161/CIRCEP.114.002065 (2015).
doi: 10.1161/CIRCEP.114.002065
pubmed: 25673629
pmcid: 4608687
Mutlu, G. M. & Sznajder, J. I. Mechanisms of pulmonary edema clearance. American Journal of Physiology. Lung Cellular and Molecular Physiology 289, L685–695, https://doi.org/10.1152/ajplung.00247.2005 (2005).
doi: 10.1152/ajplung.00247.2005
pubmed: 16214819
Downs, C. A. et al. beta-Adrenergic agonists differentially regulate highly selective and nonselective epithelial sodium channels to promote alveolar fluid clearance in vivo. American Journal of Physiology. Lung Cellular and Molecular Physiology 302, L1167–1178, https://doi.org/10.1152/ajplung.00038.2012 (2012).
doi: 10.1152/ajplung.00038.2012
pubmed: 22505670
pmcid: 3379040
Agostoni, P. et al. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? European Journal of Heart Failure 9, 827–833, https://doi.org/10.1016/j.ejheart.2007.04.006 (2007).
doi: 10.1016/j.ejheart.2007.04.006
pubmed: 17561440
Contini, M. et al. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial. International Journal of Cardiology 168, 2134–2140, https://doi.org/10.1016/j.ijcard.2013.01.277 (2013).
doi: 10.1016/j.ijcard.2013.01.277
pubmed: 23506636
Di Marco, F. et al. Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study. Pulmonary Pharmacology & Therapeutics 25, 119–123, https://doi.org/10.1016/j.pupt.2011.12.010 (2012).
doi: 10.1016/j.pupt.2011.12.010
Taylor, B. J. et al. Effect of beta2-adrenergic receptor stimulation on lung fluid in stable heart failure patients. The Journal of Heart and Lung Transplantation: the official Publication of the International Society for Heart Transplantation 36, 418–426, https://doi.org/10.1016/j.healun.2016.09.008 (2017).
doi: 10.1016/j.healun.2016.09.008
Culver, B. H. et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. American Journal of Respiratory and Critical Care Medicine 196, 1463–1472, https://doi.org/10.1164/rccm.201710-1981ST (2017).
doi: 10.1164/rccm.201710-1981ST
pubmed: 29192835
Quanjer, P. H. et al. Lung volumes and forced ventilatory flows. The European Respiratory Journal 6(Suppl 16), 5–40, https://doi.org/10.1183/09041950.005s1693 (1993).
doi: 10.1183/09041950.005s1693
pubmed: 24576915
Roughton, F. J. & Forster, R. E. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. Journal of Applied Physiology 11, 290–302, https://doi.org/10.1152/jappl.1957.11.2.290 (1957).
doi: 10.1152/jappl.1957.11.2.290
pubmed: 13475180
Agostoni, P. et al. Work-rate affects cardiopulmonary exercise test results in heart failure. European Journal of Heart Failure 7, 498–504, https://doi.org/10.1016/j.ejheart.2004.06.007 (2005).
doi: 10.1016/j.ejheart.2004.06.007
pubmed: 15921786
Agostoni, P. & Dumitrescu, D. How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure. International Journal of Cardiology 288, 107–113, https://doi.org/10.1016/j.ijcard.2019.04.053 (2019).
doi: 10.1016/j.ijcard.2019.04.053
pubmed: 31047701
Berry, R. B. et al. AASM Scoring Manual Updates for 2017 (Version 2.4). Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine 13, 665–666, https://doi.org/10.5664/jcsm.6576 (2017).
doi: 10.5664/jcsm.6576
Senn, S. Cross-over Trials in Clinical Research, 2nd Edition. (Wiley, 2002).
Hawkins, N. M., Virani, S. & Ceconi, C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. European Heart Journal 34, 2795–2803, https://doi.org/10.1093/eurheartj/eht192 (2013).
doi: 10.1093/eurheartj/eht192
pubmed: 23832490
Salpeter, S. R., Ormiston, T. M. & Salpeter, E. E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 125, 2309–2321, https://doi.org/10.1378/chest.125.6.2309 (2004).
doi: 10.1378/chest.125.6.2309
pubmed: 15189956
Juvelekian, G. et al. A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study. International Journal of Chronic Obstructive Pulmonary Disease 10, 2109–2120, https://doi.org/10.2147/COPD.S83071 (2015).
doi: 10.2147/COPD.S83071
pubmed: 26491281
pmcid: 4599566
Agostoni, P. et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. European Heart Journal 27, 2538–2543, https://doi.org/10.1093/eurheartj/ehl302 (2006).
doi: 10.1093/eurheartj/ehl302
pubmed: 17028107
Agostoni, P. et al. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. European Journal of Heart Failure 8, 729–735, https://doi.org/10.1016/j.ejheart.2006.02.001 (2006).
doi: 10.1016/j.ejheart.2006.02.001
pubmed: 16533619
Agostoni, P., Guazzi, M., Bussotti, M., De Vita, S. & Palermo, P. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest 122, 2062–2067, https://doi.org/10.1378/chest.122.6.2062 (2002).
doi: 10.1378/chest.122.6.2062
pubmed: 12475848
Paolillo, S. et al. Role of alveolar beta2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans. PloS One 8, e61877, https://doi.org/10.1371/journal.pone.0061877 (2013).
doi: 10.1371/journal.pone.0061877
pubmed: 23613962
pmcid: 3627811
Clark, A. L., Poole-Wilson, P. A. & Coats, A. J. Relation between ventilation and carbon dioxide production in patients with chronic heart failure. Journal of the American College of Cardiology 20, 1326–1332 (1992).
doi: 10.1016/0735-1097(92)90244-H
Whipp, B. J. Ventilatory control during exercise in humans. Annual Review of Physiology 45, 393–413, https://doi.org/10.1146/annurev.ph.45.030183.002141 (1983).
doi: 10.1146/annurev.ph.45.030183.002141
pubmed: 6405676
Patrick, J. M. & Pearson, S. B. Propranolol and the ventilatory response to CO
pubmed: 206686
Lymperopoulos, A. Arrestins in the Cardiovascular System: An Update. Progress in Molecular Biology and Translational Science 159, 27–57, https://doi.org/10.1016/bs.pmbts.2018.07.003 (2018).
doi: 10.1016/bs.pmbts.2018.07.003
pubmed: 30340788
Desimine, V. L. et al. Biased Agonism/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy. International Review of Cell and Molecular Biology 339, 41–61, https://doi.org/10.1016/bs.ircmb.2018.02.007 (2018).
doi: 10.1016/bs.ircmb.2018.02.007
pubmed: 29776604